A small company biotechnology of Pennsylvania plans for the start of the application of a potential vaccine against the coronavirus Covid-19 healthy volunteers during this week, after having received the regulatory authorization to begin clinical trials.
According to the report, the researchers plan to inject the first-person this Monday.
The experimental vaccine it was developed by Inovio Pharmaceuticalsand the funding has been provided by the Bill and Melinda Gates Foundation and the Coalition for the innovations of preparation for epidemics.
The candidate Inovio, called INO-4800, is the second potential vaccine against the coronavirus that started human trials in the united States.
Anthony Fauci, american medical doctor specialized in immunology, has repeatedly said that it will take at least a year to know if a vaccine is safe and effective against the virus.
With information from Business Insider.